Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
FDA approves Denali's Hunter syndrome drug
In approving Avlayah, the FDA has greenlit the first treatment for Hunter syndrome that addresses the condition’s pernicious cognitive symptoms.
Darren Incorvaia
Mar 25, 2026 2:50pm
Fierce Madness Drug Name Tournament 2026—Sweet 16 voting open
Mar 24, 2026 4:15pm
AI is Transforming MLR—but Flexibility is What Will Make it Work
Brought to you by
ERMA Systems
Takeda targets $1.3B in savings with new efficiency drive
Mar 25, 2026 10:44am
As questions swirl, Alnylam eyes ATTR market leadership by 2030
Mar 26, 2026 2:08pm
New egg-based drugmaker Neion Bio strikes biosimilar collab
Mar 26, 2026 1:00pm
More News
Genentech walks the walk in lupus as sponsor of annual event
Mar 26, 2026 11:20am
ACIP adviser exits as legal ruling keeps vaccine panel on ice
Mar 26, 2026 11:18am
How pharma marketers can capitalize on HCPs’ digital habits
Mar 25, 2026 3:46pm
Corcept wins FDA nod for relacorilant in ovarian cancer
Mar 25, 2026 3:00pm